Others have shown a role for Usp22 in regulating anti-tumor immunity through the modulation of T-regs [32, 33] and future studies using deletion or overexpression of Usp22 in Tregs within a mouse breast cancer model could lead to significant insights to how Usp22 overexpression affects tumorigenesis. The gene discussed is USP22; the disease is breast carcinoma.